|
Zydus Lifesciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
119842.47 Cr.
|
P/BV
|
4.42
|
Book Value (Rs.)
|
269.43
|
|
52 Week High/Low (Rs.)
|
1182/836
|
FV/ML
|
1/1
|
P/E(X)
|
23.78
|
|
Bookclosure
|
24/07/2026
|
EPS (Rs.)
|
50.09
|
Div Yield (%)
|
0.08
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 50.09 | 44.97 | 38.14 | 19.30 | 43.83 |
| Diluted EPS (Rs.) | 50.09 | 44.97 | 38.14 | 19.30 | 43.83 |
| Cash EPS (Rs.) | 63.96 | 54.98 | 45.91 | 26.88 | 51.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 269.50 | 238.10 | 219.70 | 194.55 | 186.07 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 269.50 | 238.10 | 219.70 | 194.55 | 186.07 |
| Revenue From Operations / Share (Rs.) | 269.86 | 231.03 | 194.31 | 170.33 | 149.07 |
| PBDIT / Share (Rs.) | 89.31 | 72.84 | 56.35 | 39.99 | 34.82 |
| PBIT / Share (Rs.) | 75.31 | 63.74 | 48.75 | 32.84 | 27.86 |
| PBT / Share (Rs.) | 65.82 | 59.91 | 47.80 | 25.59 | 27.72 |
| Net Profit / Share (Rs.) | 49.96 | 45.87 | 38.31 | 19.74 | 44.65 |
| NP After MI And SOA / Share (Rs.) | 50.10 | 44.98 | 38.36 | 19.37 | 43.82 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 33.09 | 31.52 | 28.99 | 23.47 | 23.35 |
| PBIT Margin (%) | 27.90 | 27.58 | 25.08 | 19.28 | 18.68 |
| PBT Margin (%) | 24.38 | 25.93 | 24.60 | 15.02 | 18.59 |
| Net Profit Margin (%) | 18.51 | 19.85 | 19.71 | 11.58 | 29.95 |
| NP After MI And SOA Margin (%) | 18.56 | 19.47 | 19.74 | 11.37 | 29.39 |
| Return on Networth / Equity (%) | 18.58 | 18.89 | 19.46 | 11.19 | 26.39 |
| Return on Capital Employeed (%) | 20.64 | 22.77 | 20.48 | 16.43 | 14.29 |
| Return On Assets (%) | 9.61 | 12.16 | 13.18 | 7.61 | 16.14 |
| Long Term Debt / Equity (X) | 0.11 | 0.00 | 0.00 | 0.00 | 0.02 |
| Total Debt / Equity (X) | 0.43 | 0.13 | 0.03 | 0.06 | 0.24 |
| Asset Turnover Ratio (%) | 0.60 | 0.69 | 0.71 | 0.64 | 0.38 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.27 | 1.89 | 2.15 | 1.81 | 1.56 |
| Quick Ratio (X) | 0.90 | 1.45 | 1.51 | 1.19 | 1.09 |
| Inventory Turnover Ratio (X) | 5.67 | 6.29 | 1.34 | 1.16 | 1.02 |
| Dividend Payout Ratio (NP) (%) | 21.96 | 6.67 | 16.08 | 13.59 | 8.29 |
| Dividend Payout Ratio (CP) (%) | 17.16 | 5.54 | 13.42 | 9.93 | 7.15 |
| Earning Retention Ratio (%) | 78.04 | 93.33 | 83.92 | 86.41 | 91.71 |
| Cash Earning Retention Ratio (%) | 82.84 | 94.46 | 86.58 | 90.07 | 92.85 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 20.47 | 44.17 | 69.81 | 31.15 | 28.07 |
| Interest Coverage Ratio (Post Tax) (%) | 13.63 | 30.14 | 48.36 | 21.06 | 18.43 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 100466.42 | 91719.42 | 103063.75 | 52502.40 | 40850.18 |
| EV / Net Operating Revenue (X) | 3.70 | 3.95 | 5.27 | 3.05 | 2.68 |
| EV / EBITDA (X) | 11.18 | 12.52 | 18.18 | 12.97 | 11.46 |
| MarketCap / Net Operating Revenue (X) | 3.23 | 3.83 | 5.17 | 2.89 | 2.34 |
| Retention Ratios (%) | 78.03 | 93.32 | 83.91 | 86.40 | 91.70 |
| Price / BV (X) | 3.23 | 3.72 | 5.10 | 2.84 | 2.10 |
| Price / Net Operating Revenue (X) | 3.23 | 3.83 | 5.17 | 2.89 | 2.34 |
| EarningsYield | 0.05 | 0.05 | 0.03 | 0.03 | 0.12 |
